292 related articles for article (PubMed ID: 15817614)
1. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model.
Waters DJ; Shen S; Glickman LT; Cooley DM; Bostwick DG; Qian J; Combs GF; Morris JS
Carcinogenesis; 2005 Jul; 26(7):1256-62. PubMed ID: 15817614
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytes.
Waters DJ; Shen S; Xu H; Kengeri SS; Cooley DM; Chiang EC; Chen Y; Schlittler D; Oteham C; Combs GF; Glickman LT; Morris JS; Bostwick DG
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1906-10. PubMed ID: 17855713
[TBL] [Abstract][Full Text] [Related]
4. DNA stability and serum selenium levels in a high-risk group for prostate cancer.
Karunasinghe N; Ryan J; Tuckey J; Masters J; Jamieson M; Clarke LC; Marshall JR; Ferguson LR
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):391-7. PubMed ID: 15006914
[TBL] [Abstract][Full Text] [Related]
5. Five threads: How U-shaped thinking weaves together dogs, men, selenium, and prostate cancer risk.
Waters DJ; Chiang EC
Free Radic Biol Med; 2018 Nov; 127():36-45. PubMed ID: 29305107
[TBL] [Abstract][Full Text] [Related]
6. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women.
Waters DJ; Chiang EC; Cooley DM; Morris JS
Mutat Res; 2004 Jul; 551(1-2):91-107. PubMed ID: 15225584
[TBL] [Abstract][Full Text] [Related]
7. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
[TBL] [Abstract][Full Text] [Related]
8. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
9. Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis.
Waters DJ; Shen S; Kengeri SS; Chiang EC; Combs GF; Morris JS; Bostwick DG
Nutrients; 2012 Nov; 4(11):1650-63. PubMed ID: 23201838
[TBL] [Abstract][Full Text] [Related]
10. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study.
Sabichi AL; Lee JJ; Taylor RJ; Thompson IM; Miles BJ; Tangen CM; Minasian LM; Pisters LL; Caton JR; Basler JW; Lerner SP; Menter DG; Marshall JR; Crawford ED; Lippman SM
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2178-84. PubMed ID: 16609032
[TBL] [Abstract][Full Text] [Related]
11. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
[TBL] [Abstract][Full Text] [Related]
12. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate.
Waters DJ; Shen S; Cooley DM; Bostwick DG; Qian J; Combs GF; Glickman LT; Oteham C; Schlittler D; Morris JS
J Natl Cancer Inst; 2003 Feb; 95(3):237-41. PubMed ID: 12569146
[TBL] [Abstract][Full Text] [Related]
13. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design.
Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):145-151. PubMed ID: 12497090
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
Venkateswaran V; Fleshner NE; Klotz LH
Prostate Cancer Prostatic Dis; 2004; 7(1):54-6. PubMed ID: 14745439
[TBL] [Abstract][Full Text] [Related]
15. A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Dunn BK; Richmond ES; Minasian LM; Ryan AM; Ford LG
Nutr Cancer; 2010; 62(7):896-918. PubMed ID: 20924966
[TBL] [Abstract][Full Text] [Related]
16. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Marshall JR
Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
[TBL] [Abstract][Full Text] [Related]
17. Dietary cancer and prevention using antimutagens.
Ferguson LR; Philpott M; Karunasinghe N
Toxicology; 2004 May; 198(1-3):147-59. PubMed ID: 15138038
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
19. Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center.
Grainger EM; Kim HS; Monk JP; Lemeshow SA; Gong M; Bahnson RR; Clinton SK
Urol Oncol; 2008; 26(2):125-32. PubMed ID: 18312929
[TBL] [Abstract][Full Text] [Related]
20. Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship between Selenium Status, DNA Damage, and Apoptosis.
Chiang EC; Shen S; Kengeri SS; Xu H; Combs GF; Morris JS; Bostwick DG; Waters DJ
Dose Response; 2009 Dec; 8(3):285-300. PubMed ID: 20877485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
